{"protocolSection": {"identificationModule": {"nctId": "NCT01332357", "orgStudyIdInfo": {"id": "112606"}, "organization": {"fullName": "GlaxoSmithKline", "class": "INDUSTRY"}, "briefTitle": "Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit", "officialTitle": "Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit"}, "statusModule": {"statusVerifiedDate": "2017-06", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2009-06"}, "primaryCompletionDateStruct": {"date": "2010-07", "type": "ACTUAL"}, "completionDateStruct": {"date": "2010-07", "type": "ACTUAL"}, "studyFirstSubmitDate": "2011-04-07", "studyFirstSubmitQcDate": "2011-04-07", "studyFirstPostDateStruct": {"date": "2011-04-11", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2011-09-08", "resultsFirstSubmitQcDate": "2011-09-08", "resultsFirstPostDateStruct": {"date": "2011-10-13", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2017-06-06", "lastUpdatePostDateStruct": {"date": "2017-07-06", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "GlaxoSmithKline", "class": "INDUSTRY"}}, "descriptionModule": {"briefSummary": "The objective of this study is to compare readmission to the emergency department for asthma in asthma patients who receive treatment with fluticasone propionate and salmeterol oral inhaler after an initial emergency department visit using a retrospective observational cohort study design."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["fluticasone/propionate salmeterol combination", "hospitalization", "emergency department", "asthma"]}, "designModule": {"studyType": "OBSERVATIONAL", "designInfo": {"observationalModel": "COHORT", "timePerspective": "RETROSPECTIVE"}, "enrollmentInfo": {"count": 6139, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Fluticasone propionate/salmeterol combination ED MD", "description": "Asthma subjects discharged from an institution after treatment for severe asthma exacerbation that receive fluticasone propionate/salmeterol combination from the ED physician", "interventionNames": ["Drug: Fluticasone propionate/salmeterol combination ED MD"]}, {"label": "Fluticasone propionate/salmeterol combination OP MD", "description": "Asthma subjects discharged from an institution after treatment for severe asthma exacerbation that receive fluticasone propionate/salmeterol combination from the OP physician", "interventionNames": ["Drug: Fluticasone propionate/salmeterol combination OP MD"]}], "interventions": [{"type": "DRUG", "name": "Fluticasone propionate/salmeterol combination ED MD", "description": "Receipt of fluticasone propionate/salmeterol combination from the ED physician", "armGroupLabels": ["Fluticasone propionate/salmeterol combination ED MD"]}, {"type": "DRUG", "name": "Fluticasone propionate/salmeterol combination OP MD", "description": "Receipt of fluticasone propionate/salmeterol combination from the OP physician", "armGroupLabels": ["Fluticasone propionate/salmeterol combination OP MD"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Number of Participants With an Asthma-related Event Occurring Between 1 and 6 Months Following the Index Event", "description": "A subsequent asthma-related inpatient (IP) visit or emergency department (ED) visit were defined as visits within 6 months of the index event. The index event was defined as an asthma-related hospitalization or ED visit occuring between 2004 and 2008.", "timeFrame": "Data were collected during a 4-year period from January 1, 2004 to December 31, 2008."}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Subjects with asthma as determined by ICD-9 codes and asthma drug use\n* at least 12 years of age\n* discharged from an initial Emergency Department visit within 12 months\n\nExclusion Criteria:\n\n* Subjects with COPD or treatment for COPD", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "12 Years", "stdAges": ["CHILD", "ADULT", "OLDER_ADULT"], "studyPopulation": "The study intends to identify subjects with asthma discharged from an emergency department that received fluticasone propionate/salmeterol from either an ED physician or from an outpatient physician", "samplingMethod": "PROBABILITY_SAMPLE"}, "contactsLocationsModule": {"overallOfficials": [{"name": "GSK Clinical Trials", "affiliation": "GlaxoSmithKline", "role": "STUDY_DIRECTOR"}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "Participants were not recruited for, nor enrolled in, this study. This study is a retrospective observational study. Data from medical records or insurance claims databases are anonymized and used to develop a cohort. All diagnoses and treatments are recorded in the course of routine medical practice.", "groups": [{"id": "FG000", "title": "Total Population", "description": "Adult and pediatric participants with persistent asthma were identified from commercially-insured and Medicaid health plan members with both medical and pharmacy benefits who had data in one of two healthcare claims databases."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "6139"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "6139"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Total Population", "description": "Adult and pediatric participants with persistent asthma were identified from commercially-insured and Medicaid health plan members with both medical and pharmacy benefits who had data in one of two healthcare claims databases."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "6139"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "22.36", "spread": "17.30"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "3392"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "2747"}]}]}]}, {"title": "Type of Index Event", "description": "The number of inpatient visits and emergency department visits that defined the index event are reported.", "paramType": "NUMBER", "unitOfMeasure": "visits", "classes": [{"title": "Inpatient hospitalizations", "categories": [{"measurements": [{"groupId": "BG000", "value": "1331"}]}]}, {"title": "Emergency Department Visit", "categories": [{"measurements": [{"groupId": "BG000", "value": "4808"}]}]}]}, {"title": "Charlson Comorbidity Index Scores", "description": "The Charlson Comorbidity Index estimates 10-year mortality risk. Scores range from 0 - 37, with a lower score indicating a higher chance of survival.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "scores on a scale", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "1.14", "spread": "0.57"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Number of Participants With an Asthma-related Event Occurring Between 1 and 6 Months Following the Index Event", "description": "A subsequent asthma-related inpatient (IP) visit or emergency department (ED) visit were defined as visits within 6 months of the index event. The index event was defined as an asthma-related hospitalization or ED visit occuring between 2004 and 2008.", "populationDescription": "Adult and pediatric participants with persistent asthma were identified from commercially-insured and Medicaid health plan members with both medical and pharmacy benefits who had data in one of two healthcare claims databases.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "Data were collected during a 4-year period from January 1, 2004 to December 31, 2008.", "groups": [{"id": "OG000", "title": "Total Population", "description": "Adult and pediatric participants with persistent asthma were identified from commercially-insured and Medicaid health plan members with both medical and pharmacy benefits who had data in one of two healthcare claims databases."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "6139"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "915"}]}]}], "analyses": [{"groupIds": ["OG000"], "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<0.0001", "pValueComment": "The unadjusted risk of experiencing a recurrent event associated with not initiating a controller medication at index event discharge", "statisticalMethod": "Regression, Cox", "paramType": "Hazard Ratio (HR)", "paramValue": "1.96", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "1.56", "ciUpperLimit": "2.46"}, {"groupIds": ["OG000"], "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<0.0001", "pValueComment": "The adjusted risk of experiencing a recurrent event associated with not initiating a controller medication at index event discharge", "statisticalMethod": "Regression, Cox", "statisticalComment": "Covariates included demographics, IP or ED index event, primary asthma diagnosis, Charlson score, and pre-index medication", "paramType": "Hazard Ratio (HR)", "paramValue": "1.79", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "1.42", "ciUpperLimit": "2.25"}, {"groupIds": ["OG000"], "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<0.0001", "pValueComment": "The risk of experiencing a recurrent event associated with not initiating a controller medication at index event discharge by time interaction", "statisticalMethod": "Regression, Cox", "statisticalComment": "Evaluates the impact of each day treatment with a controller was delayed", "paramType": "Hazard Ratio (HR)", "paramValue": "1.008", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "1.005", "ciUpperLimit": "1.011"}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "description": "This is a retrospective study of pre-existing medical records and/or health insurance claims data; all data are de-identified, and thus no assessments of Serious or Non-serious Adverse Events are possible.", "eventGroups": [{"id": "EG000", "title": "Total Population", "description": "Adult and pediatric participants with persistent asthma were identified from commercially-insured and Medicaid health plan members with both medical and pharmacy benefits who had data in one of two healthcare claims databases.", "seriousNumAffected": 0, "seriousNumAtRisk": 0, "otherNumAffected": 0, "otherNumAtRisk": 0}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial."}, "pointOfContact": {"title": "GSK Response Center", "organization": "GlaxoSmithKline", "phone": "866-435-7343"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000004630", "term": "Emergencies"}], "ancestors": [{"id": "D000020969", "term": "Disease Attributes"}, {"id": "D000010335", "term": "Pathologic Processes"}], "browseLeaves": [{"id": "M7796", "name": "Emergencies", "asFound": "Emergency", "relevance": "HIGH"}, {"id": "M4556", "name": "Asthma", "relevance": "LOW"}, {"id": "M22700", "name": "Disease Attributes", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000068298", "term": "Fluticasone"}, {"id": "C000716389", "term": "Xhance"}, {"id": "D000068299", "term": "Salmeterol Xinafoate"}, {"id": "D000068297", "term": "Fluticasone-Salmeterol Drug Combination"}], "ancestors": [{"id": "D000000893", "term": "Anti-Inflammatory Agents"}, {"id": "D000001993", "term": "Bronchodilator Agents"}, {"id": "D000001337", "term": "Autonomic Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000018927", "term": "Anti-Asthmatic Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000003879", "term": "Dermatologic Agents"}, {"id": "D000018926", "term": "Anti-Allergic Agents"}, {"id": "D000058666", "term": "Adrenergic beta-2 Receptor Agonists"}, {"id": "D000000318", "term": "Adrenergic beta-Agonists"}, {"id": "D000000322", "term": "Adrenergic Agonists"}, {"id": "D000018663", "term": "Adrenergic Agents"}, {"id": "D000018377", "term": "Neurotransmitter Agents"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}, {"id": "D000005938", "term": "Glucocorticoids"}, {"id": "D000006728", "term": "Hormones"}, {"id": "D000006730", "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"id": "D000013566", "term": "Sympathomimetics"}], "browseLeaves": [{"id": "M250", "name": "Fluticasone", "asFound": "Pembrolizumab", "relevance": "HIGH"}, {"id": "M353494", "name": "Xhance", "asFound": "Membrane", "relevance": "HIGH"}, {"id": "M251", "name": "Salmeterol Xinafoate", "asFound": "Metabolism", "relevance": "HIGH"}, {"id": "M249", "name": "Fluticasone-Salmeterol Drug Combination", "asFound": "Hours per day", "relevance": "HIGH"}, {"id": "M4217", "name": "Anti-Inflammatory Agents", "relevance": "LOW"}, {"id": "M5269", "name": "Bronchodilator Agents", "relevance": "LOW"}, {"id": "M20963", "name": "Anti-Asthmatic Agents", "relevance": "LOW"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M7074", "name": "Dermatologic Agents", "relevance": "LOW"}, {"id": "M20962", "name": "Anti-Allergic Agents", "relevance": "LOW"}, {"id": "M20746", "name": "Adrenergic Agents", "relevance": "LOW"}, {"id": "M3670", "name": "Adrenergic beta-Agonists", "relevance": "LOW"}, {"id": "M3673", "name": "Adrenergic Agonists", "relevance": "LOW"}, {"id": "M20504", "name": "Neurotransmitter Agents", "relevance": "LOW"}, {"id": "M9047", "name": "Glucocorticoids", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M9788", "name": "Hormone Antagonists", "relevance": "LOW"}, {"id": "M16345", "name": "Sympathomimetics", "relevance": "LOW"}], "browseBranches": [{"abbrev": "AAll", "name": "Anti-Allergic Agents"}, {"abbrev": "Infl", "name": "Anti-Inflammatory Agents"}, {"abbrev": "Derm", "name": "Dermatologic Agents"}, {"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}